Darwin Advisors, LLC Zoetis Inc. Transaction History

Darwin Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$155.97 - $200.09 $490,837 - $629,683	-3,147 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$181.39 - $234.03 $80,537 - $103,909	444 Added 16.43%	3,147 $593,000
Q4 2021 Jan 21, 2022	BUY	$193.69 - $247.03 $171,221 - $218,374	884 Added 48.6%	2,703 $546,000
Q3 2021 Oct 27, 2021	BUY	$189.29 - $209.69 $14,575 - $16,146	77 Added 4.42%	1,819 $353,000
Q2 2021 Aug 12, 2021	SELL	$155.9 - $187.99 $4.87 Million - $5.87 Million	-31,227 Reduced 94.72%	1,742 $325,000
Q1 2021 May 17, 2021	BUY	$144.0 - $169.39 $349,632 - $411,278	2,428 Added 7.95%	32,969 $5.19 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $778,595 - $864,252	4,957 Added 19.38%	30,541 $5.05 Million
Q3 2020 Oct 16, 2020	BUY	$137.1 - $165.37 $2.99 Million - $3.61 Million	21,820 Added 579.7%	25,584 $4.23 Million
Q2 2020 Aug 06, 2020	BUY	$111.92 - $142.53 $411,753 - $524,367	3,679 Added 4328.24%	3,764 $515,000
Q1 2020 May 01, 2020	BUY	$92.66 - $144.94 $7,876 - $12,319	85 New	85 $10,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Darwin Advisors, LLC with notifications on news.